Skip to main content
REPLIGEN CORP logo

REPLIGEN CORP — Investor Relations & Filings

Ticker · RGEN ISIN · US7599161095 LEI · 54930006QJ0T5AUO1E71 US Manufacturing
Filings indexed 1,029 across all filing types
Latest filing 2026-03-03 Director's Dealing
Country US United States of America
Listing US RGEN

About REPLIGEN CORP

https://www.repligen.com/

Repligen Corporation is a life sciences company that develops and commercializes innovative bioprocessing technologies and systems used in the manufacturing of biologic drugs. The company's portfolio is focused on enhancing efficiency and quality in biopharmaceutical production workflows. Key product areas include filtration, featuring Tangential Flow Filtration (TFF) systems; fluid management, with single-use technologies such as bags, assemblies, and mixers; and process analytics, offering advanced instruments for concentration measurement. Repligen's technologies are integral to the development and cGMP manufacturing of therapies like monoclonal antibodies, vaccines, and cell and gene therapies.

Recent filings

Filing Released Lang Actions
4 - REPLIGEN CORP (0000730272) (Filer)
Director's Dealing
2026-03-03 English
4 - REPLIGEN CORP (0000730272) (Filer)
Director's Dealing
2026-03-03 English
4 - REPLIGEN CORP (0000730272) (Filer)
Director's Dealing
2026-03-03 English
10-K - REPLIGEN CORP (0000730272) (Filer)
Annual Report FY 2025
2026-02-26 English
8-K - REPLIGEN CORP (0000730272) (Filer)
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated February 24, 2026, reporting the announcement of financial results for the fourth quarter and year ended December 31, 2025. It includes a press release as an exhibit but does not contain the full financial statements or detailed financial analysis itself. The text states that the press release is attached as an exhibit, indicating this document is primarily an announcement of earnings results rather than the earnings release itself. Given the Form 8-K nature and the content focusing on announcing financial results, this fits the category of an Earnings Release (ER). The document length is under 5,000 characters, consistent with a brief announcement rather than a full report.
2026-02-24 English
Major Shareholding Notification 2026
Major Shareholding Notification
2026-02-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.